Abstract
Purpose
Although C-reactive protein to prealbumin ratio (CPR) can predict the outcomes of several types of cancer surgeries, little is known about the implication of CPR in patients undergoing esophagectomy for esophageal squamous cell carcinoma (ESCC).
Methods
Between 2009 and 2018, 682 consecutive ESCC patients who underwent curative esophagectomy were enrolled. The clinicopathological factors and prognoses were compared between the groups stratified by preoperative CPR levels. A logistic regression model was used to determine the risk factors of postoperative pneumonia. Survival curves were constructed using the Kaplan–Meier method and compared using the log-rank test. The Cox proportional hazards model was used to elucidate prognostic factors.
Results
There were more elderly patients, more males, and more advanced clinical T and N categories in the high CPR group than in the low CPR group. Also, the incidence of postoperative pneumonia was significantly higher in the high CPR group than in the low CPR group (32.4% vs. 20.3%, p < 0.01). In multivariate analyses, high CPR was one of the independent predictive factors for postoperative pneumonia (OR, 1.71; 95% CI, 1.15–2.54; p < 0.03). Moreover, high CPR was an independent prognostic factor for overall, cancer-specific, and recurrence-free survivals (HR 1.62; 95% CI 1.18–2.23; p < 0.01, HR 1.57; 95% CI 1.08–2.32; p = 0.02, HR 1.42; 95% CI 1.06–1.90; p = 0.02).
Conclusion
Preoperative CPR was found to be a useful inflammatory and nutritional indicator for predicting the occurrence of pneumonia and prognosis in patients with ESCC undergoing esophagectomy.
Similar content being viewed by others
References
Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F (2021) Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71:209–249. https://doi.org/10.3322/caac.21660
Enzinger PC, Mayer RJ (2003) Esophageal cancer. N Engl J Med 349:2241–2252. https://doi.org/10.1056/NEJMra035010
Lagergren J, Smyth E, Cunningham D, Lagergren P (2017) Oesophageal cancer. Lancet 390:2383–2396. https://doi.org/10.1016/s0140-6736(17)31462-9
Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68:394–424. https://doi.org/10.3322/caac.21492
Mantovani A, Allavena P, Sica A, Balkwill F (2008) Cancer-related inflammation. Nature 454:436–444. https://doi.org/10.1038/nature07205
Balkwill F, Mantovani A (2001) Inflammation and cancer: back to Virchow? Lancet 357:539–545. https://doi.org/10.1016/s0140-6736(00)04046-0
Szkandera J, Stotz M, Absenger G, Stojakovic T, Samonigg H, Kornprat P, Schaberl-Moser R, Alzoughbi W, Lackner C, Ress AL, Seggewies FS, Gerger A, Hoefler G, Pichler M (2014) Validation of C-reactive protein levels as a prognostic indicator for survival in a large cohort of pancreatic cancer patients. Br J Cancer 110:183–188. https://doi.org/10.1038/bjc.2013.701
Kinoshita A, Onoda H, Imai N, Iwaku A, Oishi M, Fushiya N, Koike K, Nishino H, Tajiri H (2012) Comparison of the prognostic value of inflammation-based prognostic scores in patients with hepatocellular carcinoma. Br J Cancer 107:988–993. https://doi.org/10.1038/bjc.2012.354
Fearon KC, Voss AC, Hustead DS (2006) Definition of cancer cachexia: effect of weight loss, reduced food intake, and systemic inflammation on functional status and prognosis. Am J Clin Nutr 83:1345–1350. https://doi.org/10.1093/ajcn/83.6.1345
Norman K, Pichard C, Lochs H, Pirlich M (2008) Prognostic impact of disease-related malnutrition. Clin Nutr 27:5–15. https://doi.org/10.1016/j.clnu.2007.10.007
Slattery E, Patchett S (2011) Albumin as a marker of nutrition: a common pitfall. Ann Surg 254:667-668 author reply 668. https://doi.org/10.1097/SLA.0b013e318230646a
Davis CJ, Sowa D, Keim KS, Kinnare K, Peterson S (2012) The use of prealbumin and C-reactive protein for monitoring nutrition support in adult patients receiving enteral nutrition in an urban medical center. JPEN J Parenter Enteral Nutr 36:197–204. https://doi.org/10.1177/0148607111413896
Shimura T, Shibata M, Gonda K, Okayama H, Saito M, Momma T, Ohki S, Kono K (2018) Serum transthyretin level is associated with prognosis of patients with gastric cancer. J Surg Res 227:145–150. https://doi.org/10.1016/j.jss.2018.02.035
Kawai H, Ota H (2012) Low perioperative serum prealbumin predicts early recurrence after curative pulmonary resection for non-small-cell lung cancer. World J Surg 36:2853–2857. https://doi.org/10.1007/s00268-012-1766-y
Lu J, Xu BB, Zheng ZF, Xie JW, Wang JB, Lin JX, Chen QY, Cao LL, Lin M, Tu RH, Huang ZN, Zheng CH, Huang CM, Li P (2019) CRP/prealbumin, a novel inflammatory index for predicting recurrence after radical resection in gastric cancer patients: post hoc analysis of a randomized phase III trial. Gastric Cancer 22:536–545. https://doi.org/10.1007/s10120-018-0892-0
Miyata H, Yamasaki M, Kurokawa Y, Takiguchi S, Nakajima K, Fujiwara Y, Mori M, Doki Y (2011) Prognostic value of an inflammation-based score in patients undergoing pre-operative chemotherapy followed by surgery for esophageal cancer. Exp Ther Med 2:879–885. https://doi.org/10.3892/etm.2011.308
Chen S, Yang X, Feng JF (2016) A novel inflammation-based prognostic score for patients with esophageal squamous cell carcinoma: the c-reactive protein/prognostic nutritional index ratio. Oncotarget 7:62123–62132. https://doi.org/10.18632/oncotarget.11389
Xie X, Luo KJ, Hu Y, Wang JY, Chen J (2016) Prognostic value of preoperative platelet-lymphocyte and neutrophil-lymphocyte ratio in patients undergoing surgery for esophageal squamous cell cancer. Dis Esophagus 29:79–85. https://doi.org/10.1111/dote.12296
Urabe M, Ueno M, Ogawa Y, Yago A, Shimoyama H, Honda A, Ohkura Y, Haruta S, Udagawa H (2021) Comparative analysis of the prognostic utility of preoperative nutritional parameters in patients with resectable esophageal carcinoma. Gen Thorac Cardiovasc Surg 69:326–335. https://doi.org/10.1007/s11748-020-01555-4
Brierley JDGM, (eds) WC (2017) TNM classification of malignant tumors. Oxford 8
Mayhew D, Mendonca V, Murthy BVS (2019) A review of ASA physical status - historical perspectives and modern developments. Anaesthesia 74:373–379. https://doi.org/10.1111/anae.14569
Clavien PA, Barkun J, de Oliveira ML, Vauthey JN, Dindo D, Schulick RD, de Santibanes E, Pekolj J, Slankamenac K, Bassi C, Graf R, Vonlanthen R, Padbury R, Cameron JL, Makuuchi M (2009) The Clavien-Dindo classification of surgical complications: five-year experience. Ann Surg 250:187–196. https://doi.org/10.1097/SLA.0b013e3181b13ca2
Kitagawa Y, Uno T, Oyama T, Kato K, Kato H, Kawakubo H, Kawamura O, Kusano M, Kuwano M, Takeuchi H, Toh Y, Doki Y, Naomoto Y, Nemoto K, Booka E, Matsubara H, Miyazaki T, Muto M, Yanagisawa A, Yoshida M (2019) Esophageal cancer practice guidelines 2017 edited by the Japan Esophageal Society: part 1. Esophagus 16:1–24. https://doi.org/10.1007/s10388-018-0641-9
Kitagawa Y, Uno T, Oyama T, Kato K, Kato H, Kawakubo H, Kawamura O, Kusano M, Kuwano H, Takeuchi H, Toh Y, Doki Y, Naomoto Y, Nemoto K, Booka E, Matsubara H, Miyazaki T, Muto M, Yanagisawa A, Yoshida M (2019) Esophageal cancer practice guidelines 2017 edited by the Japan esophageal society: part 2. Esophagus 16:25–43. https://doi.org/10.1007/s10388-018-0642-8
Kanda Y (2013) Investigation of the freely available easy-to-use software ‘EZR’ for medical statistics. Bone Marrow Transplant 48:452–458. https://doi.org/10.1038/bmt.2012.244
Sansone P, Storci G, Tavolari S, Guarnieri T, Giovannini C, Taffurelli M, Ceccarelli C, Santini D, Paterini P, Marcu KB, Chieco P, Bonafè M (2007) IL-6 triggers malignant features in mammospheres from human ductal breast carcinoma and normal mammary gland. J Clin Invest 117:3988–4002. https://doi.org/10.1172/jci32533
Gabay C, Kushner I (1999) Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 340:448–454. https://doi.org/10.1056/nejm199902113400607
Zingg U, Forberger J, Rajcic B, Langton C, Jamieson GG (2010) Association of C-reactive protein levels and long-term survival after neoadjuvant therapy and esophagectomy for esophageal cancer. J Gastrointest Surg 14:462–469. https://doi.org/10.1007/s11605-009-1113-2
Shimada H, Nabeya Y, Okazumi S, Matsubara H, Shiratori T, Aoki T, Sugaya M, Miyazawa Y, Hayashi H, Miyazaki S, Ochiai T (2003) Elevation of preoperative serum C-reactive protein level is related to poor prognosis in esophageal squamous cell carcinoma. J Surg Oncol 83:248–252. https://doi.org/10.1002/jso.10275
Okamura A, Yamashita K, Kozuki R, Takahashi K, Toihata T, Imamura Y, Mine S, Watanabe M (2019) Inflammatory response and recurrence after minimally invasive esophagectomy. Langenbecks Arch Surg. https://doi.org/10.1007/s00423-019-01818-6
Chandra RK, Kumari S (1994) Nutrition and immunity: an overview. J Nutr 124:1433s–1435s. https://doi.org/10.1093/jn/124.suppl_8.1433S
Marcos A, Nova E, Montero A (2003) Changes in the immune system are conditioned by nutrition. Eur J Clin Nutr 57(Suppl 1):S66-69. https://doi.org/10.1038/sj.ejcn.1601819
Feng JF, Wang L, Jiang YH, Yang X (2019) C-Reactive Protein to Prealbumin Ratio (CPR): A novel inflammatory-nutritional prognostic factor for predicting cancer-specific survival (CSS) and overall survival (OS) in Patients with resectable esophageal squamous cell carcinoma. J Oncol 2019:4359103.:https://doi.org/10.1155/2019/4359103
Bountziouka V, Panagiotakos DB (2010) Statistical methods used for the evaluation of reliability and validity of nutrition assessment tools used in medical research. Curr Pharm Des 16:3770–3675. https://doi.org/10.2174/138161210794455102
Hayashi M, Takeuchi H, Nakamura R, Suda K, Wada N, Kawakubo H, Kitagawa Y (2020) Determination of the optimal surgical procedure by identifying risk factors for pneumonia after transthoracic esophagectomy. Esophagus 17:50–58. https://doi.org/10.1007/s10388-019-00692-x
Ozawa S, Koyanagi K, Ninomiya Y, Yatabe K, Higuchi T (2020) Postoperative complications of minimally invasive esophagectomy for esophageal cancer. Ann Gastroenterol Surg 4:126–134. https://doi.org/10.1002/ags3.12315
Takeuchi H, Miyata H, Ozawa S, Udagawa H, Osugi H, Matsubara H, Konno H, Seto Y, Kitagawa Y (2017) Comparison of short-term outcomes between open and minimally invasive esophagectomy for esophageal cancer using a nationwide database in Japan. Ann Surg Oncol 24:1821–1827. https://doi.org/10.1245/s10434-017-5808-4
Jie B, Jiang ZM, Nolan MT, Zhu SN, Yu K, Kondrup J (2012) Impact of preoperative nutritional support on clinical outcome in abdominal surgical patients at nutritional risk. Nutrition 28:1022–1027. https://doi.org/10.1016/j.nut.2012.01.017
Weimann A, Braga M, Carli F, Higashiguchi T, Hübner M, Klek S, Laviano A, Ljungqvist O, Lobo DN, Martindale R, Waitzberg DL, Bischoff SC, Singer P (2017) ESPEN guideline: Clinical nutrition in surgery. Clin Nutr 36:623–650. https://doi.org/10.1016/j.clnu.2017.02.013
Hua X, Phipps AI, Burnett-Hartman AN, Adams SV, Hardikar S, Cohen SA, Kocarnik JM, Ahnen DJ, Lindor NM, Baron JA, Newcomb PA (2017) Timing of aspirin and other nonsteroidal anti-inflammatory drug use among patients with colorectal cancer in relation to tumor markers and survival. J Clin Oncol 35:2806–2813. https://doi.org/10.1200/jco.2017.72.3569
Walker AJ, Grainge MJ, Card TR (2012) Aspirin and other non-steroidal anti-inflammatory drug use and colorectal cancer survival: a cohort study. Br J Cancer 107:1602–1607. https://doi.org/10.1038/bjc.2012.427
Chan AT, Ogino S, Fuchs CS (2009) Aspirin use and survival after diagnosis of colorectal cancer. Jama 302:649–658. https://doi.org/10.1001/jama.2009.1112
Author information
Authors and Affiliations
Contributions
Study concept and design: MS, OA, and WM. Performance of operation: OA, KJ, IY, and WM. Draft the manuscript: MS, OA, and WM. Acquisition of data: MS, KY, SK, and FD. Analysis and interpretation of data: MS, OA, KK, and WM. All authors have revised and approved the manuscript.
Corresponding author
Ethics declarations
Informed consent statement
All study participants provided informed written consent prior to their study enrollment.
This study was approved by the institutional review board and performed under the ethical standards of the Declaration of Helsinki and its later amendments.
Conflict of interest
The authors declare no competing interests.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Maruyama, S., Okamura, A., Kanie, Y. et al. C-reactive protein to prealbumin ratio: a useful inflammatory and nutritional index for predicting prognosis after curative resection in esophageal squamous cell carcinoma patients. Langenbecks Arch Surg 407, 1901–1909 (2022). https://doi.org/10.1007/s00423-022-02508-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00423-022-02508-6